Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04127500Unknown
Randomised trial of dexmedetomidine in delirium (2 arms), sponsored by Nanjing First Hospital. Primary endpoints: Delirium incidence at 1 month and alpha7nAChR level at 7 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04127500.